FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Michele Dal Bo

Research Profile

Disorders

B-Cell Chronic Lymphocytic Leukemia

Chemicals & Drugs

Physiology

Genes & Molecular Sequences

Genes, Immunoglobulin Heavy Chain

Procedures

Concepts & Ideas

Anatomy

Chromosomes, Human, Pair 13

Co-author Network

Publications

TOP 3
Michele Dal Bo; Massimo Degan; Giovanni Del Poeta; Gianluca Gaidano; Daniela Marconi; Gabriele Pozzato; Federico Pozzo; Davide Rossi; Giorgio Zauli; Antonella Zucchetto; Riccardo Bomben; Valter Gattei
ARHGDIA, a mutant TP53-associated Rho GDP dissociation inhibitor, is over-expressed in gene expression profiles of TP53 disrupted chronic lymphocytic leukaemia cells.
Davide Rossi; Francesca Maria Rossi; Roberto Serra; Valeria Spina; Francesco Bertoni; Alessio Bruscaggin; Pietro Bulian; Carmela Ciardullo; Michele Dal Bo; Riccardo Dalla-Favera; Clara Deambrogi; Giovanni Del Poeta; Robin Foà; Francesco Forconi; Valter Gattei; Hossein Khiabanian; Luca Laurenti; Roberto Marasca; Sara Monti; Josep Nomdedeu; Laura Pasqualucci; Raul Rabadan; Silvia Rasi; Gianluca Gaidano
Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia.
Giovanni Del Poeta; Maria Ilaria Del Principe; Gianluca Gaidano; Sergio Amadori; Riccardo Bomben; Pietro Bulian; Michele Dal Bo; Massimo Degan; Federico Pozzo; Silvia Rasi; Davide Rossi; Francesca Maria Rossi; Antonella Zucchetto; Valter Gattei
Clinical significance of c.7544-7545 delCT NOTCH1 mutation in chronic lymphocytic leukaemia.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Michele Dal Bo (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Michele Dal Bo; Massimo Degan; Giovanni Del Poeta; Gianluca Gaidano; Daniela Marconi; Gabriele Pozzato; Federico Pozzo; Davide Rossi; Giorgio Zauli; Antonella Zucchetto; Riccardo Bomben; Valter Gattei
ARHGDIA, a mutant TP53-associated Rho GDP dissociation inhibitor, is over-expressed in gene expression profiles of TP53 disrupted chronic lymphocytic leukaemia cells.
British journal of haematology 2013;161(4):596-9.
2013: Davide Rossi; Francesca Maria Rossi; Roberto Serra; Valeria Spina; Francesco Bertoni; Alessio Bruscaggin; Pietro Bulian; Carmela Ciardullo; Michele Dal Bo; Riccardo Dalla-Favera; Clara Deambrogi; Giovanni Del Poeta; Robin Foà; Francesco Forconi; Valter Gattei; Hossein Khiabanian; Luca Laurenti; Roberto Marasca; Sara Monti; Josep Nomdedeu; Laura Pasqualucci; Raul Rabadan; Silvia Rasi; Gianluca Gaidano
Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia.
Blood 2013;121(8):1403-12.
2013: Giovanni Del Poeta; Maria Ilaria Del Principe; Gianluca Gaidano; Sergio Amadori; Riccardo Bomben; Pietro Bulian; Michele Dal Bo; Massimo Degan; Federico Pozzo; Silvia Rasi; Davide Rossi; Francesca Maria Rossi; Antonella Zucchetto; Valter Gattei
Clinical significance of c.7544-7545 delCT NOTCH1 mutation in chronic lymphocytic leukaemia.
British journal of haematology 2013;160(3):415-8.
2012: Riccardo Bomben; Michele Dal Bo; Giovanni Del Poeta; Dimitar G Efremov; Gianluca Gaidano; Stefania Gobessi; Luca Laurenti; D Marconi; Davide Rossi; E Tissino; S Volinia; Antonella Zucchetto; Dania Benedetti; Valter Gattei
The miR-17∼92 family regulates the response to Toll-like receptor 9 triggering of CLL cells with unmutated IGHV genes.
Leukemia 2012;26(7):1584-93.
2012: Antonella Zucchetto; A Gorgone; F Malavasi; G Pozzato; Davide Rossi; E Tissino; Tiziana Vaisitti; Dania Benedetti; V Bertagnolo; Riccardo Bomben; Michele Dal Bo; Silvia Deaglio; Giovanni Del Poeta; Maria Ilaria Del Principe; Gianluca Gaidano; Valter Gattei
The CD49d/CD29 complex is physically and functionally associated with CD38 in B-cell chronic lymphocytic leukemia cells.
Leukemia 2012;26(6):1301-12.
2012: Giovanni Del Poeta; Valter Gattei; Fabrizio Luciano; Luca Maurillo; Benedetta Neri; Cristina Simotti; Adriano Venditti; Antonella Zucchetto; Francesca Maria Rossi; Annalisa Biagi; Riccardo Bomben; Antonio Bruno; Francesco Buccisano; Pietro Bulian; Angela Maria Coletta; Michele Dal Bo; Paolo De Fabritiis; Maria Ilaria Del Principe; Sergio Amadori
CD69 is independently prognostic in chronic lymphocytic leukemia: a comprehensive clinical and biological profiling study.
Haematologica 2012;97(2):279-87.
2012: Michele Dal Bo; Silvia Deaglio; Giovanni Del Poeta; Dimitar G Efremov; Gianluca Gaidano; Riccardo Bomben; Antonella Zucchetto; Valter Gattei
Microenvironmental interactions in chronic lymphocytic leukemia: hints for pathogenesis and identification of targets for rational therapy.
Current pharmaceutical design 2012;18(23):3323-34.
2011: Michele Dal Bo; Clara Deambrogi; Ilaria Del Giudice; Giovanni Del Poeta; Francesco Di Raimondo; Robin Foà; Francesco Forconi; Gianluca Gaidano; Alessandro Gozzetti; Anna Guarini; Ivo Kwee; Marco Ladetto; Luca Laurenti; Fabrizio Luciano; Marasca Roberto; Mauro Nanni; Giuseppe Palumbo; Gabriele Pozzato; Andrea Rinaldi; Davide Rossi; Francesca Maria Rossi; Erika Tissino; Francesco Bertoni; Pietro Bulian; Emanuele Cencini; Angela Maria Coletta; Giorgia Corradini; Valter Gattei
13q14 deletion size and number of deleted cells both influence prognosis in chronic lymphocytic leukemia.
Genes, chromosomes & cancer 2011;50(8):633-43.
2010: Riccardo Bomben; Michele Dal Bo; Dania Benedetti; Daniela Capello; Francesco Forconi; Daniela Marconi; Francesco Bertoni; Rossana Maffei; Luca Laurenti; Davide Rossi; Maria Ilaria Del Principe; Fabrizio Luciano; Elisa Sozzi; Ilaria Cattarossi; Antonella Zucchetto; Francesca Maria Rossi; Pietro Bulian; Emanuele Zucca; Milena S Nicoloso; Massimo Degan; Marasca Roberto; Dimitar G Efremov; Giovanni Del Poeta; Gianluca Gaidano; Valter Gattei
Expression of mutated IGHV3-23 genes in chronic lymphocytic leukemia identifies a disease subset with peculiar clinical and biological features.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(2):620-8.
2010: Francesca M Rossi; Maria Ilaria Del Principe; Davide Rossi; Maria Irno Consalvo; Fabrizio Luciano; Antonella Zucchetto; Pietro Bulian; Riccardo Bomben; Michele Dal Bo; Marco Fangazio; Dania Benedetti; Massimo Degan; Gianluca Gaidano; Giovanni Del Poeta; Valter Gattei
Prognostic impact of ZAP-70 expression in chronic lymphocytic leukemia: mean fluorescence intensity T/B ratio versus percentage of positive cells.
Journal of translational medicine 2010;8():23.
2009: Antonella Zucchetto; Dania Benedetti; Claudio Tripodo; Riccardo Bomben; Michele Dal Bo; Daniela Marconi; Fleur Bossi; Debora Lorenzon; Massimo Degan; Francesca Maria Rossi; Davide Rossi; Pietro Bulian; Vito Franco; Giovanni Del Poeta; Silvia Deaglio; Gianluca Gaidano; Francesco Tedesco; Fabio Malavasi; Valter Gattei
CD38/CD31, the CCL3 and CCL4 chemokines, and CD49d/vascular cell adhesion molecule-1 are interchained by sequential events sustaining chronic lymphocytic leukemia cell survival.
Cancer research 2009;69(9):4001-9.
2009: Michele Dal Bo; Francesco Bertoni; Francesco Forconi; Antonella Zucchetto; Riccardo Bomben; Marasca Roberto; Silvia Deaglio; Luca Laurenti; Dimitar G Efremov; Gianluca Gaidano; Giovanni Del Poeta; Valter Gattei
Intrinsic and extrinsic factors influencing the clinical course of B-cell chronic lymphocytic leukemia: prognostic markers with pathogenetic relevance.
Journal of translational medicine 2009;7():76.
2008: Valter Gattei; Pietro Bulian; Maria Ilaria Del Principe; Antonella Zucchetto; Luca Maurillo; Francesco Buccisano; Riccardo Bomben; Michele Dal Bo; Fabrizio Luciano; Francesca M Rossi; Massimo Degan; Sergio Amadori; Giovanni Del Poeta
Relevance of CD49d protein expression as overall survival and progressive disease prognosticator in chronic lymphocytic leukemia.
Blood 2008;111(2):865-73.
2008: Dania Benedetti; Riccardo Bomben; Michele Dal Bo; D Marconi; Antonella Zucchetto; Massimo Degan; Francesco Forconi; Giovanni Del Poeta; Gianluca Gaidano; Valter Gattei
Are surrogates of IGHV gene mutational status useful in B-cell chronic lymphocytic leukemia? The example of Septin-10.
Leukemia 2008;22(1):224-6.
2007: Riccardo Bomben; Michele Dal Bo; Daniela Capello; Dania Benedetti; Daniela Marconi; Antonella Zucchetto; Francesco Forconi; Rossana Maffei; Emanuela Ghia; Luca Laurenti; Pietro Bulian; Maria Ilaria Del Principe; Giuseppe Palermo; Mia Thorsélius; Massimo Degan; Renato Campanini; Anna Guarini; Giovanni Del Poeta; Richard Rosenquist; Dimitar G Efremov; Marasca Roberto; Robin Foà; Gianluca Gaidano; Valter Gattei
Comprehensive characterization of IGHV3-21-expressing B-cell chronic lymphocytic leukemia: an Italian multicenter study.
Blood 2007;109(7):2989-98.
2006: Daniela Capello; Antonella Zucchetto; Massimo Degan; Riccardo Bomben; Michele Dal Bo; Dimitar G Efremov; Luca Laurenti; Giovanni Del Poeta; Gianluca Gaidano; Valter Gattei
Immunophenotypic characterization of IgVH3-72 B-cell chronic lymphocytic leukaemia (B-CLL).
Leukemia research 2006;30(9):1197-9.
2006: Antonella Zucchetto; Riccardo Bomben; Michele Dal Bo; Paolo Sonego; Paola Nanni; Maurizio Rupolo; Pietro Bulian; Luigino Dal Maso; Giovanni Del Poeta; Maria Ilaria Del Principe; Massimo Degan; Valter Gattei
A scoring system based on the expression of six surface molecules allows the identification of three prognostic risk groups in B-cell chronic lymphocytic leukemia.
Journal of cellular physiology 2006;207(2):354-63.
2006: Antonella Zucchetto; Riccardo Bomben; Michele Dal Bo; Pietro Bulian; Dania Benedetti; Paola Nanni; Giovanni Del Poeta; Massimo Degan; Valter Gattei
CD49d in B-cell chronic lymphocytic leukemia: correlated expression with CD38 and prognostic relevance.
Leukemia 2006;20(3):523-5; author reply 528-9.
2006: Antonella Zucchetto; Paolo Sonego; Massimo Degan; Riccardo Bomben; Michele Dal Bo; Pietro Bulian; Dania Benedetti; Maurizio Rupolo; Giovanni Del Poeta; Renato Campanini; Valter Gattei
Surface-antigen expression profiling of B cell chronic lymphocytic leukemia: from the signature of specific disease subsets to the identification of markers with prognostic relevance.
Journal of translational medicine 2006;4():11.
2005: Massimo Degan; Antonella Zucchetto; Riccardo Bomben; Michele Dal Bo; Maurizio Rupolo; Paola Nanni; Giovanni Del Poeta; Valter Gattei
Activation-induced cytidine deaminase and CD38 expression in B-cell chronic lymphocytic leukemia.
Clinical lymphoma & myeloma 2005;6(3):251-2.
2005: Antonella Zucchetto; Paolo Sonego; Massimo Degan; Riccardo Bomben; Michele Dal Bo; Stefania Russo; Vincenza Attadia; Maurizio Rupolo; Francesco Buccisano; Agostino Steffan; Giovanni Del Poeta; Carlo Pucillo; Alfonso Colombatti; Renato Campanini; Valter Gattei
Surface-antigen expression profiling (SEP) in B-cell chronic lymphocytic leukemia (B-CLL): Identification of markers with prognostic relevance.
Journal of immunological methods 2005;305(1):20-32.
2005: Riccardo Bomben; Michele Dal Bo; Antonella Zucchetto; E Zaina; Paola Nanni; Paolo Sonego; Giovanni Del Poeta; Massimo Degan; Valter Gattei
Mutational status of IgV(H) genes in B-cell chronic lymphocytic leukemia and prognosis: percent mutations or antigen-driven selection?
Leukemia 2005;19(8):1490-2.
2005: Antonella Zucchetto; Paolo Sonego; Massimo Degan; Riccardo Bomben; Michele Dal Bo; Stefania Russo; Vincenza Attadia; Maurizio Rupolo; Francesco Buccisano; Maria Ilaria Del Principe; Giovanni Del Poeta; Carlo Pucillo; Alfonso Colombatti; Renato Campanini; Valter Gattei
Signature of B-CLL with different prognosis by Shrunken centroids of surface antigen expression profiling.
Journal of cellular physiology 2005;204(1):113-23.